News | December 28, 2024
Sterling Biotech and Zydus Lifesciences agree to extend completion of business transfer
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
Divestment is part of BASF’s strategic portfolio optimization
Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
The company has received the GMP Certification after successful closure of the inspection
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
Lidocaine and Prilocaine cream had annual sales of US $22.05 million in the United States (IQVIA MAT October 2024)
Subscribe To Our Newsletter & Stay Updated
